KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Staar Surgical (STAA) Long-Term Investments (2022 - 2024)

Staar Surgical's Long-Term Investments history spans 3 years, with the latest figure at $265000.0 for Q2 2024.

  • For Q2 2024, Long-Term Investments fell 98.49% year-over-year to $265000.0; the TTM value through Jun 2024 reached $265000.0, down 98.49%, while the annual FY2023 figure was $11.7 million, 15.82% down from the prior year.
  • Long-Term Investments reached $265000.0 in Q2 2024 per STAA's latest filing, down from $7.0 million in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $17.5 million in Q2 2023 to a low of $265000.0 in Q2 2024.
  • Average Long-Term Investments over 3 years is $11.3 million, with a median of $13.4 million recorded in 2022.
  • Peak YoY movement for Long-Term Investments: rose 2.0% in 2023, then crashed 98.49% in 2024.
  • A 3-year view of Long-Term Investments shows it stood at $13.9 million in 2022, then dropped by 15.82% to $11.7 million in 2023, then crashed by 97.74% to $265000.0 in 2024.
  • Per Business Quant, the three most recent readings for STAA's Long-Term Investments are $265000.0 (Q2 2024), $7.0 million (Q1 2024), and $11.7 million (Q4 2023).